[go: up one dir, main page]

ES2188344A1 - Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos. - Google Patents

Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.

Info

Publication number
ES2188344A1
ES2188344A1 ES200002914A ES200002914A ES2188344A1 ES 2188344 A1 ES2188344 A1 ES 2188344A1 ES 200002914 A ES200002914 A ES 200002914A ES 200002914 A ES200002914 A ES 200002914A ES 2188344 A1 ES2188344 A1 ES 2188344A1
Authority
ES
Spain
Prior art keywords
preparation
derivative compounds
benzothiophene derivative
medicine
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200002914A
Other languages
English (en)
Other versions
ES2188344B1 (es
Inventor
Castillo Nieto Juan Carlos Del
Aldaz Berta Lasheras
Vega Antonio Monge
Mancini Marisabel Mourelle
Rio Zambrana Joaquin Del
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200002914A priority Critical patent/ES2188344B1/es
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to HR20030407A priority patent/HRP20030407A2/hr
Priority to KR10-2003-7007272A priority patent/KR20030066689A/ko
Priority to ES01983737T priority patent/ES2225623T3/es
Priority to OA1200300144A priority patent/OA12536A/en
Priority to JP2002546540A priority patent/JP2004514719A/ja
Priority to HU0303568A priority patent/HUP0303568A3/hu
Priority to CA002429892A priority patent/CA2429892A1/en
Priority to SK620-2003A priority patent/SK6202003A3/sk
Priority to AU2002215157A priority patent/AU2002215157A1/en
Priority to CNA018196004A priority patent/CN1478088A/zh
Priority to GE5158A priority patent/GEP20043366B/en
Priority to US10/432,697 priority patent/US20040034219A1/en
Priority to IL15596601A priority patent/IL155966A0/xx
Priority to SI200130192T priority patent/SI1337528T1/xx
Priority to PT01983737T priority patent/PT1337528E/pt
Priority to PL01362982A priority patent/PL362982A1/xx
Priority to EEP200300245A priority patent/EE200300245A/xx
Priority to EP01983737A priority patent/EP1337528B1/en
Priority to EA200300519A priority patent/EA200300519A1/ru
Priority to MXPA03004875A priority patent/MXPA03004875A/es
Priority to BR0115708-6A priority patent/BR0115708A/pt
Priority to APAP/P/2003/002801A priority patent/AP2003002801A0/en
Priority to PCT/IB2001/002211 priority patent/WO2002044170A2/en
Priority to NZ525950A priority patent/NZ525950A/en
Priority to CZ20031398A priority patent/CZ20031398A3/cs
Priority to TR2004/02779T priority patent/TR200402779T4/xx
Priority to DE60104717T priority patent/DE60104717T2/de
Priority to AT01983737T priority patent/ATE272634T1/de
Priority to PE2001001181A priority patent/PE20020692A1/es
Priority to ARP010105490A priority patent/AR034009A1/es
Priority to MA27164A priority patent/MA26963A1/fr
Priority to ZA200303858A priority patent/ZA200303858B/en
Priority to IS6824A priority patent/IS6824A/is
Priority to NO20032332A priority patent/NO20032332D0/no
Priority to BG107851A priority patent/BG107851A/bg
Publication of ES2188344A1 publication Critical patent/ES2188344A1/es
Application granted granted Critical
Publication of ES2188344B1 publication Critical patent/ES2188344B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thin Film Transistor (AREA)

Abstract

Compuestos derivados de benzotiofeno, su procedimiento de obtención y utilización de los mismos. La presente invención proporciona nuevos derivados de benzotiofeno de fórmula general (I) así como un procedimiento para su obtención, las correspondientes composiciones y su utilización para la fabricación de un medicamento destinado al tratamiento de trastornos neurológicos. Estos nuevos compuestos se comportan como inhibidores de la receptación de serotonina y muestran elevada afinidad hacia el receptor 5-HT1A.
ES200002914A 2000-11-29 2000-11-29 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos. Expired - Fee Related ES2188344B1 (es)

Priority Applications (36)

Application Number Priority Date Filing Date Title
ES200002914A ES2188344B1 (es) 2000-11-29 2000-11-29 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
EA200300519A EA200300519A1 (ru) 2000-11-29 2001-11-19 Соединения производных бензотиофена, способ их получения и применения
ES01983737T ES2225623T3 (es) 2000-11-29 2001-11-19 Compuestos derivados de benzotiofeno, su procedimdiento de obtencion y utilizacion de los mismos.
OA1200300144A OA12536A (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof.
JP2002546540A JP2004514719A (ja) 2000-11-29 2001-11-19 ベンゾチオフェン誘導体化合物、その製造方法および使用
HU0303568A HUP0303568A3 (en) 2000-11-29 2001-11-19 Benzothiophene derivatives, process for their preparation and use thereof
CA002429892A CA2429892A1 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
SK620-2003A SK6202003A3 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of the preparation and use thereof
AU2002215157A AU2002215157A1 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
CNA018196004A CN1478088A (zh) 2000-11-29 2001-11-19 苯并噻吩衍生物、其制备方法以及应用
GE5158A GEP20043366B (en) 2000-11-29 2001-11-19 Benzothiophene Derivative Compounds Process of Preparation and Use Thereof
US10/432,697 US20040034219A1 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds process of preparation and use thereof
IL15596601A IL155966A0 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
SI200130192T SI1337528T1 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
KR10-2003-7007272A KR20030066689A (ko) 2000-11-29 2001-11-19 벤조티오펜 유도체 화합물, 이의 제조방법 및 용도
PL01362982A PL362982A1 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process for the preparation and use thereof
EEP200300245A EE200300245A (et) 2000-11-29 2001-11-19 Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
EP01983737A EP1337528B1 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
HR20030407A HRP20030407A2 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
PT01983737T PT1337528E (pt) 2000-11-29 2001-11-19 Compostos derivados de benzotiofeno, processo de preparacao e a sua utilizacao
TR2004/02779T TR200402779T4 (tr) 2000-11-29 2001-11-19 Benzotiyofen türevi bileşikler, bunların hazırlama yöntemleri ve kullanımları.
APAP/P/2003/002801A AP2003002801A0 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
PCT/IB2001/002211 WO2002044170A2 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof
NZ525950A NZ525950A (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof as serotonin reuptake inhibitors with affinity to the 5-HT1A receptor to treat neurological disorders such as psychosis, depression, anxiety and panic attacks
CZ20031398A CZ20031398A3 (cs) 2000-11-29 2001-11-19 Deriváty benzothiofenových sloučenin, způsob jejich přípravy a jejich použití
BR0115708-6A BR0115708A (pt) 2000-11-29 2001-11-19 Compostos derivados de benzotiofeno, seu processo de obten-ção e uso dos mesmos
DE60104717T DE60104717T2 (de) 2000-11-29 2001-11-19 Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
AT01983737T ATE272634T1 (de) 2000-11-29 2001-11-19 Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
MXPA03004875A MXPA03004875A (es) 2000-11-29 2001-11-19 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
PE2001001181A PE20020692A1 (es) 2000-11-29 2001-11-26 Compuestos derivados de benzotiofeno y su procedimiento de obtencion
ARP010105490A AR034009A1 (es) 2000-11-29 2001-11-27 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos
MA27164A MA26963A1 (fr) 2000-11-29 2003-05-19 Composes derives de benzothiophene, procede de leur preparation et leur utilisation.
ZA200303858A ZA200303858B (en) 2000-11-29 2003-05-19 Benzothiophene derivative compounds, process of preparation and use thereof.
IS6824A IS6824A (is) 2000-11-29 2003-05-22 Bensóþíófenafleiðuefnasambönd, aðferð við að framleiða og nota þau
NO20032332A NO20032332D0 (no) 2000-11-29 2003-05-22 Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
BG107851A BG107851A (bg) 2000-11-29 2003-05-27 Съединения, производни на бензотиофена, метод за тяхното получаване и използването им

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200002914A ES2188344B1 (es) 2000-11-29 2000-11-29 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.

Publications (2)

Publication Number Publication Date
ES2188344A1 true ES2188344A1 (es) 2003-06-16
ES2188344B1 ES2188344B1 (es) 2004-09-16

Family

ID=8495887

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200002914A Expired - Fee Related ES2188344B1 (es) 2000-11-29 2000-11-29 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
ES01983737T Expired - Lifetime ES2225623T3 (es) 2000-11-29 2001-11-19 Compuestos derivados de benzotiofeno, su procedimdiento de obtencion y utilizacion de los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01983737T Expired - Lifetime ES2225623T3 (es) 2000-11-29 2001-11-19 Compuestos derivados de benzotiofeno, su procedimdiento de obtencion y utilizacion de los mismos.

Country Status (35)

Country Link
US (1) US20040034219A1 (es)
EP (1) EP1337528B1 (es)
JP (1) JP2004514719A (es)
KR (1) KR20030066689A (es)
CN (1) CN1478088A (es)
AP (1) AP2003002801A0 (es)
AR (1) AR034009A1 (es)
AT (1) ATE272634T1 (es)
AU (1) AU2002215157A1 (es)
BG (1) BG107851A (es)
BR (1) BR0115708A (es)
CA (1) CA2429892A1 (es)
CZ (1) CZ20031398A3 (es)
DE (1) DE60104717T2 (es)
EA (1) EA200300519A1 (es)
EE (1) EE200300245A (es)
ES (2) ES2188344B1 (es)
GE (1) GEP20043366B (es)
HR (1) HRP20030407A2 (es)
HU (1) HUP0303568A3 (es)
IL (1) IL155966A0 (es)
IS (1) IS6824A (es)
MA (1) MA26963A1 (es)
MX (1) MXPA03004875A (es)
NO (1) NO20032332D0 (es)
NZ (1) NZ525950A (es)
OA (1) OA12536A (es)
PE (1) PE20020692A1 (es)
PL (1) PL362982A1 (es)
PT (1) PT1337528E (es)
SI (1) SI1337528T1 (es)
SK (1) SK6202003A3 (es)
TR (1) TR200402779T4 (es)
WO (1) WO2002044170A2 (es)
ZA (1) ZA200303858B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007956A1 (en) * 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7452888B2 (en) 2002-03-27 2008-11-18 Glaxo Group Limited Quinoline derivatives and their use as 5-ht6 ligands
KR20050094843A (ko) 2003-01-13 2005-09-28 다이노젠 파마세우티컬스, 인코포레이티드 욕지기, 구토, 구역질 또는 이들의 조합을 치료하는 방법
US7276603B2 (en) * 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
BRPI0412263B1 (pt) 2003-07-22 2019-10-15 Arena Pharmaceuticals, Inc. Derivados de diaril e aril heteroaril uréia, uso e composição farmacêutica contendo os mesmos, bem como processo para preparação da dita composição
DE102004023508A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Säurederivate substituierter Cyclohexyl-1,4-diamine
DE102004023635A1 (de) * 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023507A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate
DE102004023632A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Substituierte Cyclohexylcarbonsäure-Derivate
DE102004023522A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023501A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023506A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
US7881267B2 (en) * 2004-06-04 2011-02-01 Hewlett-Packard Development Company, L.P. Portable computing device for wireless communications and method of operation
DE102004063797A1 (de) * 2004-12-30 2006-07-13 Schwarz Pharma Ag Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
EP2254564A1 (en) 2007-12-12 2010-12-01 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
CN101619056B (zh) * 2008-07-02 2013-07-17 石药集团中奇制药技术（石家庄）有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
US9598401B2 (en) 2013-07-29 2017-03-21 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
WO2016201373A1 (en) 2015-06-12 2016-12-15 Axovant Sciences Ltd. Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder
CA2992518A1 (en) 2015-07-15 2017-01-19 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0574313A1 (fr) * 1992-06-12 1993-12-15 Adir Et Compagnie Pipérazines 1,4-disubstituées pour le traitement des maladies du système nerveux central et des maladies neuro endocriniennes
WO1996015792A1 (en) * 1994-11-17 1996-05-30 Molecular Geriatrics Corporation Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones
WO1999002516A1 (es) * 1997-07-08 1999-01-21 Vita-Invest, S.A. Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0574313A1 (fr) * 1992-06-12 1993-12-15 Adir Et Compagnie Pipérazines 1,4-disubstituées pour le traitement des maladies du système nerveux central et des maladies neuro endocriniennes
WO1996015792A1 (en) * 1994-11-17 1996-05-30 Molecular Geriatrics Corporation Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones
WO1999002516A1 (es) * 1997-07-08 1999-01-21 Vita-Invest, S.A. Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes

Also Published As

Publication number Publication date
ES2225623T3 (es) 2005-03-16
MA26963A1 (fr) 2004-12-20
DE60104717T2 (de) 2006-04-06
HUP0303568A3 (en) 2005-02-28
EE200300245A (et) 2003-08-15
CZ20031398A3 (cs) 2004-01-14
AR034009A1 (es) 2004-01-21
NO20032332L (no) 2003-05-22
WO2002044170A2 (en) 2002-06-06
CA2429892A1 (en) 2002-06-06
NO20032332D0 (no) 2003-05-22
BG107851A (bg) 2004-06-30
HRP20030407A2 (en) 2004-08-31
NZ525950A (en) 2004-11-26
IS6824A (is) 2003-05-22
MXPA03004875A (es) 2005-02-14
PE20020692A1 (es) 2002-09-02
HUP0303568A2 (hu) 2004-03-01
US20040034219A1 (en) 2004-02-19
CN1478088A (zh) 2004-02-25
EP1337528B1 (en) 2004-08-04
DE60104717D1 (de) 2004-09-09
BR0115708A (pt) 2004-02-03
SK6202003A3 (en) 2004-05-04
PT1337528E (pt) 2004-11-30
OA12536A (en) 2006-06-05
ATE272634T1 (de) 2004-08-15
JP2004514719A (ja) 2004-05-20
IL155966A0 (en) 2003-12-23
KR20030066689A (ko) 2003-08-09
WO2002044170A3 (en) 2002-09-06
ES2188344B1 (es) 2004-09-16
ZA200303858B (en) 2004-05-19
EP1337528A2 (en) 2003-08-27
TR200402779T4 (tr) 2004-11-22
AP2003002801A0 (en) 2003-06-30
GEP20043366B (en) 2004-04-13
EA200300519A1 (ru) 2003-12-25
AU2002215157A1 (en) 2002-06-11
PL362982A1 (en) 2004-11-02
SI1337528T1 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
AP2003002801A0 (en) Benzothiophene derivative compounds, process of preparation and use thereof
PT1353672E (pt) Síntese da 4-amino talidomida enantiómeros
MX2007012883A (es) Derivados de dihidrobenzofurano y usos de los mismos.
HUP0400343A2 (hu) Ciklopropil-indol-származékok mint szelektív szerotonin-újrafelvétel inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
WO2002085925A3 (en) Melanocortin receptor ligands
UA83862C2 (ru) Производные тиазола как модуляторы рецепторов канабиноидов
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
TW200519075A (en) Novel compounds
PL370381A1 (en) Substituted piperazines as modulators of the melanocortin receptor
HK1049333A1 (zh) 以环状琥珀酸酯代替内酰胺，作为制造Aβ蛋白质的抑制剂
MXPA04004498A (es) Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion.
SI1506185T1 (sl) Spojine in njihova uporaba kot inhibitorji 5-HT
TW200504069A (en) Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
NO20050838L (no) Nye pyrazolforbindelser som transformerende vekstfaktor (TGF)-inhibitorer
MXPA02012270A (es) Derivados de sulfonil-pirrolidina.
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
TW200514781A (en) Novel compounds
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
TW200509933A (en) Therapeutic agents
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
SI1673354T1 (sl) Arilindenopiridini in arilindenopirimidini in njihova uporaba kot antagonisti adenozinskih A2a-receptorjev
WO2000069424A3 (en) Method of treating psychotic disorders
IL158828A0 (en) Novel heteroaryl derivatives, their preparation and use
AU2251801A (en) Piperidine derivatives and their use as serotonin receptor antagonists

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030616

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2188344B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312